UNSPSC 51143002: Aceglutamide

This classification denotes a cns stimulant with the molecular formula C7H12N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01J18G9G97, chemically known as l-glutamine, n2-acetyl- but generally known as aceglutamide, which bears US NIH Compound Identifier 25561. Aceglutamide most often arises in forms base and aluminium. European Medicines Agency schedules Aceglutamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05208MIG. The term ACEGLUTAMIDE is an International Non-Proprietary Name.

UNSPSC 51143002 Aceglutamide is a Commodity code that covers the procurement of aceglutamide, a pharmaceutical compound used in medical and research contexts. State and local governments rarely solicit this substance directly through public notice; activity under this code is sparse and typically limited to specialized medical facilities, research institutions, and healthcare systems with specific therapeutic or investigative protocols requiring the compound. When procured, aceglutamide is sourced through established pharmaceutical vendors or contract manufacturers rather than through competitive bidding processes visible in standard state and local procurement channels.

The source materials provided contain no recent state and local contract opportunities posted under this code as of October 2026. Given the specialized pharmaceutical nature of aceglutamide and its limited medical application, procurement activity under this Commodity code remains below the visibility threshold of typical state and local solicitation databases. Entities requiring aceglutamide are more likely to source it through existing pharmaceutical supply agreements, direct vendor relationships, or specialized medical procurement frameworks than through open RFP, RFQ, IFB, or ITB processes.